Prognosis in patients with other forms of pulmonary hypertension depends on the underlying disease as well as right ventricular function. For instance, patients with COPD and moderate airflow ...

The following is a summary of “Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with ...

Eko Health developed an AI algorithm that, combined with noninvasive heart tests, may be able to accurately identify pulmonary hypertension.

Columnist Anna Jeter reflects on her mental health needs and various treatment approaches since being diagnosed with PH at ...

Pulmonary hypertension is a common complication of systemic sclerosis and generally portends a very poor prognosis. Response to modern therapy for scleroderma-related pulmonary arterial ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on strong efficacy shown in previous studies, the drugmaker said on Thursday.

Seropositive rheumatoid arthritis may be protective against the development of PAH, based on results of Mendelian randomization analyses.

Novel PET approach identifies early signs of pulmonary arterial hypertension. ScienceDaily . Retrieved February 11, 2025 from www.sciencedaily.com / releases / 2025 / 01 / 250122145809.htm ...

Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta: Shardul Nautiyal, Mumbai Saturday, February 8, 2025, 08:00 Hrs [IST] Dr Ma ...